Mindray

Profile narrative

Mindray is a global medical technology company headquartered in China that designs, manufactures, and markets a wide range of medical equipment and solutions for healthcare providers. Its product portfolio includes patient monitoring systems, life support devices such as ventilators and anaesthesia machines, in‑vitro diagnostic reagents, ultrasound imaging systems, and surgical equipment used across specialties like cardiology, obstetrics, intensive care, and emergency medicine. These devices are deployed in hospitals, clinics, and other clinical settings to support diagnosis, treatment, and patient monitoring, helping healthcare professionals deliver timely and effective care. Mindray distributes its products through a worldwide sales and service network, serving customers in both domestic and international markets.

The company places a strong emphasis on research and development, operating multiple R&D centers that focus on advancing technologies in medical imaging, patient monitoring, and diagnostics. This commitment to innovation is reflected in a substantial number of patents and ongoing collaborations with academic institutions and healthcare partners to refine existing products and introduce new solutions. Mindray’s manufacturing and quality management processes comply with international standards such as ISO 13485 and CE marking, enabling its products to meet regulatory requirements in diverse jurisdictions. In addition to product development, the company provides comprehensive after‑sales support, including technical training, maintenance services, and software updates, to ensure the reliable performance of its equipment throughout its lifecycle.

In July 2026, the Cl0p ransomware group disclosed that it had exploited a vulnerability in PTC’s Windchill platform to gain unauthorized access to Mindray’s systems and exfiltrate data, among other organizations. According to the group’s statements, the stolen information comprised databases, project files, backups, images, engineering documents, blueprints, diagrams, logs and other corporate files, with volumes ranging from one gigabyte to several terabytes. While much of the data may be of limited value or already public, the incident highlighted the cybersecurity challenges faced by medical technology firms that manage sensitive intellectual property and operational information. The breach attracted attention from industry observers and underscored the need for robust protective measures to safeguard critical assets in the healthcare sector.

Incidents

1 incident linked to this organisation.